Chris Yates Email

Senior Director, Medicinal Chemistry . Rgenta

Current Roles

Employees:
39
Revenue:
$7.8M
About
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Our lead programs and unique approach are unlocking the therapeutic potential of historically undruggable targets in human diseases.
Rgenta Address
300 TradeCenter
Cambridge, MA
United States
Rgenta Email

Past Companies

Rgenta Therapeutics Inc.Senior Director, Medicinal Chemistry
Kymera TherapeuticsDirector Of Chemistry
Kymera TherapeuticsAssociate Director of Chemistry

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.